Medical Devices Regulations — 81
81 The records referred to in section 80 shall contain the following: (a) the name, address and telephone number of the manufacturer and the importer of the device; (b) the name of the device, its class and its identifier, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family; (c) a description of the device and of the materials used in its manufacture and packaging; (d) a description of the features of the device that permit it to be used for the medical conditions, purposes and uses for which it is manufactured, sold or represented; (e) a list of the countries other than Canada where the device has been sold, the total number of units sold in those countries, and a summary of any reported problems with the device and any recalls of the device in those countries; (f) a risk assessment comprising an analysis and evaluation of the risks, and the risk reduction measures adopted for the purposes of conducting investigational testing of the device, including, as appropriate, (i) the results of any previous research, testing and studies conducted with respect to the device, (ii) a description of the methods currently used to diagnose or treat the medical condition in respect of which the investigational testing is being proposed, and (iii) information respecting any cautions, warnings, contra-indications and possible adverse effects associated with the use of the device; (g) the names of all the qualified investigators to whom the device is proposed to be sold and their qualifications, including their training and experience; (h) the name and address of each institution at which the investigational testing is proposed to be conducted and, in the case of a Class III or IV device, written approval from the institution indicating that the investigational testing may be carried out there; (i) a protocol of the proposed investigational testing, including the number of units of the device proposed to be used for the testing, the hypothesis for and objective of the testing, the period of time during which the testing will be carried out and a copy of the patient consent form; (j) a copy of the device label; and (k) a written undertaking from each qualified investigator to (i) conduct the investigational testing in accordance with the protocol provided by the manufacturer, (ii) inform a patient who is to be diagnosed or treated using the device of any risks and benefits associated with its use, and obtain the patient’s written consent for its use, (iii) not use the device or permit it to be used for any purpose other than the investigational testing specified in the protocol, (iv) not permit the device to be used by any other person except under the direction of the qualified investigator, and (v) in the event of an incident involving the device and that meets the following conditions, report the incident and the circumstances surrounding it to the Minister and to the manufacturer or importer of the device within 72 hours after the qualified investigator becomes aware of the incident: (A) the incident is related to a failure of the device or a deterioration in its effectiveness or any inadequacy in its labelling or in its directions for use, and (B) the incident has led to the death or a serious deterioration in the state of health of a patient, user or other person or could do so were the incident to recur. SOR/2020-262, s. 20